Autophagy genes variants and paediatric Crohn's disease phenotype: a single-centre experience

Caterina Strisciuglio1, Renata Auricchio1, Massimo Martinelli1

  • 1Department of Translational Medical Sciences, Section of Pediatrics, University of Naples "Federico II", Italy.

Insights

Genetic variants in autophagy genes are linked to a more aggressive Crohn's disease course in children. Specifically, ATG16L1 variants correlate with increased relapses and earlier immunosuppressant use in pediatric Crohn's disease patients.

Area of Science:

  • Genetics
  • Pediatric Gastroenterology
  • Immunology

Background:

  • Limited evidence exists on single nucleotide polymorphisms (SNPs) and Crohn's disease (CD) phenotypes in children.
  • Autophagy gene variants' association with pediatric CD clinical features remains under-investigated.

Purpose of the Study:

  • To investigate the relationship between autophagy gene variants (ATG16L1, NOD2/CARD15, IRGM1) and clinical features in children with Crohn's disease.

Main Methods:

  • Genotyping of ATG16L1, NOD2/CARD15, and IRGM1 in 80 pediatric CD patients.
  • Classification of disease location and behavior using the Paris classification.
  • Collection of demographic, clinical, and treatment data.

Main Results:

  • Homozygosity for ATG16L1 (T300A) risk allele showed a trend towards a stricturing phenotype (p=0.01).
  • ATG16L1 risk allele homozygosity correlated with increased relapses (p=0.006) and earlier immunosuppressant initiation (p=0.04).
  • NOD2 rs2066847 heterozygosity was linked to major ileal involvement (p=0.01).

Conclusions:

  • The T300A variant in ATG16L1 is associated with a more aggressive clinical course in pediatric Crohn's disease.
  • Specific genetic variations influence disease behavior and treatment requirements in children with Crohn's disease.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159